A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.
Ain shams university, Cairo, Egypt
The Affiliated Huaian Hospital of Xuzhou Medical University, Huai'an Second Hospital, Huaian, China
Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States
Tanta University, Tanta, El-Gharbia, Egypt
The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Alberta Children's Hospital, Calgary, Alberta, Canada
Stollery Children's Hospital, Edmonton, Ontario, Canada
McMaster Children's Hospital, Hamilton, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.